10
Views
35
CrossRef citations to date
0
Altmetric
Article

Novel Role for RbAp48 in Tissue-Specific, Estrogen Deficiency-Dependent Apoptosis in the Exocrine Glands

, , , , , & show all
Pages 2924-2935 | Received 01 Aug 2005, Accepted 20 Jan 2006, Published online: 27 Mar 2023

REFERENCES

  • Acarturk, F., and J. R. Robinson. 1996. Vaginal permeability and enzymatic activity studies in normal and ovariectomized rabbits. Pharm. Res. 13:779–783.
  • Apostolou, I., Z. Hao, K. Rajewsky, and H. von Boehmer. 2003. Effective destruction of Fas-deficient insulin-producing B cells in type 1 diabetes. J. Exp. Med. 198:1103–1106.
  • Christen, U., and M. G. Von Herrath. 2002. Apoptosis of autoreactive CD8 lymphocytes as a potential mechanism for the abrogation of type 1 diabetes by islet-specific TNF-α expression at a time when the autoimmune process is already ongoing. Ann. N. Y. Acad. Sci. 958:166–169.
  • Cryns, V. L., L. Bergeron, H. Zhu, H. Li, and J. Yuan. 1996. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J. Biol. Chem. 271:31277–31282.
  • Ding, H. F., Y. L. Lin, G. McGill, P. Juo, H. Zhu, J. Blenis, J. Yuan, and D. E. Fisher. 2000. Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J. Biol. Chem. 275:38905–38911.
  • Dou, Q. P., B. An, and P. L. Will. 1995. Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc. Natl. Acad. Sci. USA 92:9019–9023.
  • Enders, A., P. Bouillet, H. Puthalakath, Y. Xu, D. M. Tarlinton, and A. Strasser. 2003. Loss of the proapoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 198:1119–1126.
  • Field, S. J., F. Y. Tsai, F. Kuo, A. M. Zubiaga, W. G. Kaelin, Jr., D. M. Livingston, S. H. Orkin, and M. E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549–561.
  • Gdula, D. A., R. Sandaltzopoulos, T. Tsukiyama, V. Ossipow, and C. Wu. 1998. Inorganic pyrophosphatase is a component of the Drosophila nucleosome remodeling factor complex. Genes Dev. 12:3206–3216.
  • Haneji, N., T. Nakamura, K. Takio, K. Yanagi, H. Higashiyama, I. Saito, S. Noji, H. Sugino, and Y. Hayashi. 1997. Identification of α-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 276:604–607.
  • Hiebert, S. W. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13:3384–3391.
  • Hugues, S, E. Mougneau, W. Ferlin, D. Jeske, P. Hofman, D. Homann, L. Beaudoin, C. Schrike, M. Von Herrath, A. Lehuen, and N. Glaichenhaus. 2002. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic β cells. Immunity 16:169–181.
  • Ishimaru, N., K. Saegusa, K. Yanagi, N. Haneji, I. Saito, and Y. Hayashi. 1999. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis. Am. J. Pathol. 155:173–181.
  • Ishimaru, N., R. Arakaki, M. Watanabe, M. Kobayashi, K. Miyazaki, and Y. Hayashi. 2003. Development of autoimmune exocrinopathy resembling Sjogren's syndrome in estrogen deficient mice of healthy background. Am. J. Pathol. 163:1481–1490.
  • Janicke, R. U., M. L. Sprengart, M. R. Wati, and A. G. Porter. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:9357–9360.
  • Katsuda, K., M. Kataoka, F. Uno, T. Murakami, T. Kondo, J. A. Roth, N. Tanaka, and T. Fujiwara. 2002. Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene 21:2108–2113.
  • Kyprianou, N., H. F. English, N. E. Davidson, and J. T. Isaacs. 1991. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51:162–166.
  • Lai, A., J. M. Lee, W. M. Yang, J. A. DeCaprio, W. G. Kaelin, Jr., E. Seto, and P. E. Branton. 1999. RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol. Cell. Biol. 19:6632–6641.
  • Lamhamedi-Cherradi, S. E., S. J. Zheng, K. A. Maguschak, J. Peschon, and Y. H. Chen. 2003. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice. Nat. Immunol. 4:255–260.
  • Lieman, J. H., L. A. Worley, and J. W. Harbour. 2005. Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase. J. Biol. Chem. 280:10484–10490.
  • Marchenko, N. D., A. Zaika, and U. M. Moll. 2000. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 275:16202–16212.
  • Mikkelsen, T. R., J. Brandt, H. J. Larsen, B. B. Larsen, K. Poulsen, J. Ingerslev, N. Din, and J. P. Hjorth. 1992. Tissue-specific expression in the salivary glands of transgenic mice. Nucleic Acids Res. 20:2249–2255.
  • Miyagishi, M., and K. Taira. 2002. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20:497–500.
  • Murga, M., O. Fernandez-Capetillo, S. J. Field, B. Moreno, L. R. Borlado, Y. Fujiwara, D. Balomenos, A. Vicario, A. C. Carrera, S. H. Orkin, M. E. Greenberg, and A. M. Zubiaga. 2001. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15:959–970.
  • Nicolas, E., S. Ait-Si-Ali, and D. Trouche. 2001. The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein. Nucleic Acids Res. 29:3131–3136.
  • Nicolas, E., V. Morales, L. Magnaghi-Jaulin, A. Harel-Bellan, H. Richard-Foy, and D. Trouche. 2000. RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein. J. Biol. Chem. 275:9797–9804.
  • Oner, P., S. Bekpinar, F. Cinar, and A. Argun. 1994. Relationship of some endogenous sex steroid hormones to leukocyte arylsulphatase A activities in pre- and postmenopausal healthy women. Horm. Metab. Res. 26:301–304.
  • Oren, M. 2003. Decision making by p53: life, death and cancer. Cell Death Differ. 10:431–442.
  • Paramio, J. M., C. Segrelles, M. L. Casanova, and J. L. Jorcano. 2000. Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation. J. Biol. Chem. 275:41219–41226.
  • Pelzer, T., M. Schumann, M. Neumann, T. de Jager, M. Stimpel, E. Serfling, and L. Neyses. 2000. 17β-Estradiol prevents programmed cell death in cardiac myocytes. Biochem. Biophys. Res. Commun. 268:192–200.
  • Petrovsky, N., D. Silva, L. Socha, R. Slattery, and B. Charlton. 2002. The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice. Ann. N. Y. Acad. Sci. 958:204–208.
  • Pike, C. J. 1999. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72:1552–1563.
  • Qian, Y. W., and E. Y. Lee. 1995. Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast. J. Biol. Chem. 270:25507–25513.
  • Qian, Y. W., Y. C. Wang, R. E. Jr. Hollingsworth, D. Jones, N. Ling, and E. Y. Lee. 1993. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 364:648–652.
  • Rathmell, J. C., and C. B. Thompson. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109:S97–107.
  • Rogoff, H. A., M. T. Pickering, M. E. Debatis, S. Jones, and T. F. Kowalik. 2002. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol. Cell. Biol. 22:5308–5318.
  • Ruuls, S. R., R. M. Hoek, V. N. Ngo, T. McNeil, L. A. Lucian, M. J. Janatpour, H. Korner, H. Scheerens, E. M. Hessel, J. G. Cyster, L. M. McEvoy, and J. D. Sedgwick. 2001. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15:533–543.
  • Saegusa, K., N. Ishimaru, K. Yanagi, K. Mishima, R. Arakaki, T. Suda, I. Saito, and Y. Hayashi. 2002. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjogen's syndrome. J. Immunol. 169:1050–1057.
  • Saito, I., K. Haruta, M. Shimuta, H. Inoue, H. Sakurai, K. Yamada, N. Ishimaru, H. Higashiyama, T. Sumida, H. Ishida, T. Suda, T. Noda, Y. Hayashi, and K. Tsubota. 1999. Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10. J. Immunol. 162:2488–2494.
  • Shirasuna, K., M. Sato, and T. Miyazaki. 1981. A neoplastic epithelial duct cell line established form an irradiated human salivary gland. Cancer 48:745–752.
  • Spyridopoulos, I., A. Sullivan, M. Kearney, J. Isner, and D. Losordo. 1997. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 95:1505–1514.
  • Stassi, G., and R. De Maria. 2002. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2:195–204.
  • Szende, B., I. Romics, and L. Vass. 1993. Apoptosis in prostate cancer after hormonal treatment. Lancet 342:1422.
  • Tan, X., and J. Y. J. Wang. 1998. The caspase-RB connection in cell death. Trends Cell Biol. 8:116–120.
  • Vanags, D. M., M. I. Porn-Ares, S. Coppola, D. H. Burgess, and S. Orrenius. 1996. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:31075–31085.
  • Vaute, O., E. Nicolas, L. Vandel, and D. Trouche. 2002. Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases. Nucleic Acids Res. 30:475–481.
  • Vousden, K. H. 2000. p53: death star. Cell 103:691–694.
  • Wang, K. K., R. Posmantur, R. Nath, K. McGinnis, M. Whitton, R. V. Talanian, S. B. Glantz, and J. S. Morrow. 1998. Simultaneous degradation of αII- and βII-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273:22490–22497.
  • Wang, R. H., C. W. Liu, V. L. Avramis, and N. Berndt. 2001. Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene 20:6111–6122.
  • Whitacre, C. C. 2001. Sex differences in autoimmune disease. Nat. Immunol. 2:777–780.
  • Whitacre, C. C., S. C. Reingold, and P. A. O'Looney. 1999. A gender gap in autoimmunity. Science 283:1277–1278.
  • Yu, J. Y., S. L. DeRuiter, and D. L. Turner. 2002. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99:6047–6052.
  • Zhang, Q., N. Vo, and R. H. Goodman. 2000. Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB. Mol. Cell. Biol. 20:4970–4978.
  • Zhang, Y., B. O'Brien, J. Trudeau, R. Tan, P. Santamaria, and J. P. Dutz. 2002. In situ β cell death promotes priming of diabetogenic CD8 T lymphocytes. J. Immunol. 168:1466–1472.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.